The US Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services (HHS) yesterday proposed adding Bacillus cereus biovar anthracis to the list of HHS select agents and toxins as a Tier 1 Select Agent, the most concerning as a possible bioterrorism agent.
The US government is awarding $20 million in prizes for innovative ideas for the development of rapid, point-of-care diagnostic lab tests to quickly identify antibiotic-resistant bacteria, according to a National Institutes of Health (NIH) press release today.
Besides leading smallpox eradication, Henderson is also known for his role in shaping public health education and for instilling passion for solving infectious disease problems.
Deep genome sequencing of two autopsy specimens from people who died in a 1979 accident at a Soviet anthrax production facility revealed that the Bacillus anthracis is similar to a wild type strain from Russia and shows no evidence of genetic manipulation for drug resistance or other characteristics.
Michigan health officials recently announced two variant H3N2 (H3N2v) influenza illnesses in Muskegon County residents who exhibited swine at the Muskegon County fair in late July. The cases appear to be the nation's first for 2016.
A new study in The Lancet shows that C-reactive protein (CRP) testing performed at the point of care safely reduced antibiotic use in patients with acute respiratory infections in Vietnam, without compromising patients' recovery.
A new study from a team of French researchers suggests that when bacteria acquire plasmids containing drug-resistant genes, they rarely lose them.
Biotechnology firm Seres Therapeutics announced late last week that SER-109, a drug designed to treat patients with recurring Clostridium difficile infections (CDIs), failed in a phase 2 study.
After 7 days of no reported cases, the Saudi Arabia Ministry of Health (MOH) reported a new case of MERS-CoV today. The case is not related to the current outbreak at King Khalid University Hospital in Riyadh.
Yellow fever in the Democratic Republic of Congo (DRC) has been declared an epidemic in three provinces as officials report 1,000 suspected cases, Reuters reported today.
